Placebo group:Kunxian capsule and Hydroxychloroquine placebo

2 trials

Sponsors

Peking University First Hospital

Conditions

IgA nephropathy

Early Phase 1

A multicenter, randomized, controlled clinical trial of Hydroxychloroquine or new Tripterygium compound in the treatment of IgA nephropathy

RecruitingITMCTR2100004723

Peking University First HospitalIgA nephropathy

Start: 2021-04-10Updated: 2023-02-20

A multicenter, randomized, controlled clinical trial of Hydroxychloroquine or new Tripterygium compound in the treatment of IgA nephropathy

RecruitingChiCTR2100045306

Peking University First HospitalIgA nephropathy

Start: 2021-04-10Updated: 2023-01-16